EcoDrugPlus

Tachykinin Receptor 1

Ensembl ID : ENSPCTG00005015229
Gene Symbol: TACR1
3 Cross references
267 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSPCTG00005006726
Gene Symbol: TACR2
1 Cross references
199 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSPCTG00005001408
Gene Symbol: TERT
1 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSPCTG00005002127
Gene Symbol: TBXAS1
1 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSPCTG00005018572
Gene Symbol: TBXA2R
3 Cross references
192 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSPCTG00005003249
Gene Symbol: TLR2
1 Cross references
251 Possible Orthologues:

Toll Like Receptor 4

Ensembl ID : ENSPCTG00005018929
Gene Symbol: TLR4
3 Cross references
127 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSPCTG00005015071
Gene Symbol: TLR8
3 Cross references
200 Possible Orthologues:

Toll Like Receptor 9

Ensembl ID : ENSPCTG00005006260
Gene Symbol: TLR9
2 Cross references
82 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSPCTG00005008219
Gene Symbol: TAAR1
4 Cross references
602 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSPCTG00005010608
Gene Symbol: TGFBR1
3 Cross references
230 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily M Member 8

Ensembl ID : ENSPCTG00005021020
Gene Symbol: TRPM8
3 Cross references
158 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).